Skip to content
10-Q

Quarterly Report

SPARK THERAPEUTICS, INC.

0001609351-18-000072

← back to feed
Filed
Aug 8, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Aug 1, 2018 37.57M sh
Stock Repurchased Q2 2018 · Jun 30, 2018 $2.79M
Stock Repurchased restated Q2 2018 · Jun 30, 2017 $471K
Long Term Debt Q2 2018 · Jun 30, 2018 $752K
Long Term Debt Q2 2018 · Dec 31, 2017 $912K
Short Term Debt Q2 2018 · Jun 30, 2018 $317K
Short Term Debt Q2 2018 · Dec 31, 2017 $312K
Cash And Equivalents Q2 2018 · Jun 30, 2018 $201.09M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $96.75M
Cash And Equivalents restated Q2 2018 · Jun 30, 2017 $36.81M
Cash And Equivalents restated Q2 2018 · Dec 31, 2016 $58.92M
Current Liabilities Q2 2018 · Jun 30, 2018 $37.44M
Current Liabilities Q2 2018 · Dec 31, 2017 $53.69M
Total Liabilities Q2 2018 · Jun 30, 2018 $189.78M
Total Liabilities Q2 2018 · Dec 31, 2017 $103.17M
Current Assets Q2 2018 · Jun 30, 2018 $691.55M
Current Assets Q2 2018 · Dec 31, 2017 $533.17M
Total Assets Q2 2018 · Jun 30, 2018 $773.52M
Total Assets Q2 2018 · Dec 31, 2017 $616.8M
Sga Expense Q2 2018 · Jun 30, 2018 $29.75M
Sga Expense Q2 2018 · Jun 30, 2018 $63.24M
Sga Expense Q2 2018 · Jun 30, 2017 $26.73M
Sga Expense Q2 2018 · Jun 30, 2017 $48.14M
Rd Expense Q2 2018 · Jun 30, 2018 $25.52M
Rd Expense Q2 2018 · Jun 30, 2018 $55.63M
Rd Expense restated Q2 2018 · Jun 30, 2017 $32.99M
Rd Expense restated Q2 2018 · Jun 30, 2017 $65.34M
Cost Of Revenue Q2 2018 · Jun 30, 2018 $269K
Cost Of Revenue Q2 2018 · Jun 30, 2018 $390K
Cost Of Revenue Q2 2018 · Jun 30, 2017 $0
Cost Of Revenue Q2 2018 · Jun 30, 2017 $0
Shares Diluted Q2 2018 · Jun 30, 2017 30.97M sh
Shares Diluted Q2 2018 · Jun 30, 2017 30.87M sh
Capex restated Q2 2018 · Jun 30, 2017 $7.22M
Eps Diluted Q2 2018 · Jun 30, 2017 −$2.40
Eps Diluted Q2 2018 · Jun 30, 2017 −$4.10
Eps Basic Q2 2018 · Jun 30, 2017 −$2.40
Eps Basic Q2 2018 · Jun 30, 2017 −$4.10
Net Income restated Q2 2018 · Jun 30, 2017 −$74.36M
Net Income restated Q2 2018 · Jun 30, 2017 −$126.65M
Operating Income restated Q2 2018 · Jun 30, 2017 −$77M
Operating Income restated Q2 2018 · Jun 30, 2017 −$129.88M
Revenue Q2 2018 · Jun 30, 2017 $0
Revenue Q2 2018 · Jun 30, 2017 $0